Partial and full agonists of A 1 adenosine receptors

Details Partial and full agonists of A 1 adenosine receptors Partial and full agonists of A 1 adenosine receptors

2007-01-16

2007-01-16

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S046000, C536S027100, C536S027130, C536S027200, C536S027210, C536S027600, C536S027620

Reexamination Certificate

active

10770542

ABSTRACT:
Disclosed are novel compounds that are partial and full A1adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.

REFERENCES:
patent: 5578582 (1996-11-01), Knutsen et al.
patent: 5789416 (1998-08-01), Lum et al.
patent: 6211165 (2001-04-01), Liang et al.
patent: 6258793 (2001-07-01), Palle et al.
patent: 2003/0050275 (2003-03-01), Elzein et al.
patent: 0181129 (1986-05-01), None
patent: WO 98/01459 (1998-01-01), None
patent: WO 99/24449 (1999-05-01), None
patent: WO 99/24450 (1999-05-01), None
patent: WO 99/24451 (1999-05-01), None
patent: WO 99/67262 (1999-12-01), None
patent: WO 01/40243 (2001-06-01), None
Dalpiaz et al., “Thermodynamic In Vitro Studies as a Method to Investigate Behavior of Adenosine A1 Receptor Ligands”, Pharmaceutical Research, vol. 16, No. 7, pp. 1054-1058, 1999.
Ghosal et al., 3′-Deoxyribonucleosides and their derivatives as anti-amoebic agents, International Journal of Pharmaceutics, 194, pp. 15-20, 2000).
Charubala et al., “Inhibition of HIV-1 Replication by Chemically Synthesized, Nuclease-resistant, Nontoxic (2′à5′)-Oligoadenylate Agonists”, Helvetica Chimica Acta, vol. 85, pp. 2284-2299, 2002.
Van der Wenden et al., “Ribose-modified Adenosine Analogs as Potential Partial Agonists for the Adenosine Receptor”, Journal of Medicinal Chemistry, 38(20), pp. 4000-4006, 1995.
R.M. Smejkal et al. (1989) “Muscarinic receptor subtype specificity of 5′(isobutylthio)-adenosine (SIBA) and its analogues,”Gen. Pharmac., 20(3):385-392, XP008022164.
Van Der Wenden, E. et al: “5′-Substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor”, J. Med Chem, 1998, 41, pp. 102-108.
Tilburg, E. et al: “N6.5′-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor”, J. Med. Chem, 1999, 42, pp. 1393-1400.
Mathe et al: “1,2-Di-O-acetyl-5-O-benzoyl-3-deoxy-L-erythro-pentofuranose, a convenient precursor for stereospecific synthesis of nucleoside analogues with the unnatural β-L-configuration”, Carbohydrate Research, 2000, 323, pp. 226-229.
Journal of Medicinal Chemistry, “Ribose-Modified Adenosine Analogs as Potential Partial Agonists for the Adenosine Receptor”, 38(20), 4000-6, van der Wenden, et al., 1995.
Journal of Medicinal Chemistry, “3′-Deoxynucleosides. II Purine 3′-Deoxynucleosides”, 8(5), 659-53, Walton, et al., 1965.
Helvetica Chimica Acta, “Nucleotides. Part LXX Inhibition of HIV-1 Replication by Chemically Synthesized, Nuclease-Resistant, Nontoxic (2′-5′)-Oligoadenylate Agonists”, 2284-2289, Charubala, et al., 2002.
Journal of Medicinal Chemistry, “Structure-Activity Relationships of 9-Alkyladenine and Ribose-Modified Adenosine Derivatives at Rat A3 Adenosine Receptors”, 38(10), 1720-35, Jacobson, et al., 1995.

Affiliated with

Also associated with

Rating

Partial and full agonists of A 1 adenosine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Partial and full agonists of A 1 adenosine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Partial and full agonists of A 1 adenosine receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3826339